XML 103 R6.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED CONDENSED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Capital Surplus
Undivided Profits
Accumulated Other Comprehensive Income/(Loss)
Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Adjustment to reflect adoption of ASU           $ (211)  
Adjustment to reflect adoption of ASU | Accounting Standards Update 2018-02         $ 57,546 (57,546) [1]  
Balance, adjusted $ 4,580,488 $ 204,211 $ 95,624 $ 3,147,613 1,160,434 (322,825) [1] $ 295,431
Balance, beginning of period (in shares) at Dec. 31, 2017   326,736,000          
Balance, beginning of period at Dec. 31, 2017 4,580,488 $ 204,211 95,624 3,147,613 1,102,888 (265,279) [1] 295,431
Beginning balance, as adjusted at Dec. 31, 2017           (323,036)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 94,994       92,174   2,820
Other comprehensive income/(loss) (67,049)         (67,049) [1]  
Comprehensive income/(loss) 27,945       92,174 (67,049) [1] 2,820
Cash dividends declared:              
Preferred stock (1,550)       (1,550)    
Common stock (39,681)       (39,681)    
Common stock repurchased (in shares)   (110,000)          
Common stock repurchased (2,185) $ (70)   (2,115)      
Common stock issued for:              
Stock options and restricted stock - equity awards (in shares)   569,000          
Stock options and restricted stock - equity awards 4,376 $ 356   4,020      
Acquisition equity adjustment (in shares)   (1,000)          
Acquisition equity adjustment (18) $ (1)   (17)      
Stock-based compensation expense 5,906     5,906      
Dividends declared - noncontrolling interest of subsidiary preferred stock (2,820)           (2,820)
Balance, end of period (in shares) at Mar. 31, 2018   327,194,000          
Balance, end of period at Mar. 31, 2018 4,572,528 $ 204,496 95,624 3,155,407 1,211,655 (390,085) [1] 295,431
Balance, beginning of period (in shares) at Dec. 31, 2017   326,736,000          
Balance, beginning of period at Dec. 31, 2017 4,580,488 $ 204,211 95,624 3,147,613 1,102,888 (265,279) [1] 295,431
Beginning balance, as adjusted at Dec. 31, 2017           (323,036)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 455,702            
Other comprehensive income/(loss) (114,613)            
Comprehensive income/(loss) 341,089            
Cash dividends declared:              
Preferred stock (4,650)            
Balance, end of period (in shares) at Sep. 30, 2018   323,943,000          
Balance, end of period at Sep. 30, 2018 4,741,931 $ 202,464 95,624 3,101,102 1,484,959 (437,649) [1] 295,431
Balance, beginning of period (in shares) at Mar. 31, 2018   327,194,000          
Balance, beginning of period at Mar. 31, 2018 4,572,528 $ 204,496 95,624 3,155,407 1,211,655 (390,085) [1] 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 85,992       83,140   2,852
Other comprehensive income/(loss) (22,029)         (22,029) [1]  
Comprehensive income/(loss) 63,963       83,140 (22,029) [1] 2,852
Cash dividends declared:              
Preferred stock (1,550)       (1,550)    
Common stock (39,176)       (39,176)    
Common stock repurchased (in shares)   (138,000)          
Common stock repurchased (2,606) $ (86)   (2,520)      
Common stock issued for:              
Stock options and restricted stock - equity awards (in shares)   328,000          
Stock options and restricted stock - equity awards 45 $ 205   (160)      
Acquisition equity adjustment (in shares)   (2,374,000)          
Acquisition equity adjustment (46,017) $ (1,483)   (44,534)      
Stock-based compensation expense 5,547     5,547      
Dividends declared - noncontrolling interest of subsidiary preferred stock (2,852)           (2,852)
Other (in shares)   (7,000)          
Other (133) $ (5)   (128)      
Balance, end of period (in shares) at Jun. 30, 2018   325,003,000          
Balance, end of period at Jun. 30, 2018 4,549,749 $ 203,127 95,624 3,113,612 1,254,069 (412,114) [1] 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 274,716       271,833   2,883
Other comprehensive income/(loss) (25,535)         (25,535) [1]  
Comprehensive income/(loss) 249,181       271,833 (25,535) [1] 2,883
Cash dividends declared:              
Preferred stock (1,550)       (1,550)    
Common stock (39,393)       (39,393)    
Common stock repurchased (in shares) [2]   (1,077,000)          
Common stock repurchased [2] (19,206) $ (673)   (18,533)      
Common stock issued for:              
Stock options and restricted stock - equity awards (in shares)   17,000          
Stock options and restricted stock - equity awards 21 $ 10   11      
Stock-based compensation expense 6,012     6,012      
Dividends declared - noncontrolling interest of subsidiary preferred stock (2,883)           (2,883)
Balance, end of period (in shares) at Sep. 30, 2018   323,943,000          
Balance, end of period at Sep. 30, 2018 4,741,931 $ 202,464 95,624 3,101,102 1,484,959 (437,649) [1] 295,431
Balance, beginning of period (in shares) at Dec. 31, 2018   318,573,000          
Balance, beginning of period at Dec. 31, 2018 4,785,380 $ 199,108 95,624 3,029,425 1,542,408 (376,616) [3] 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 103,405       100,585   2,820
Other comprehensive income/(loss) 55,465         55,465 [3]  
Comprehensive income/(loss) 158,870       100,585 55,465 [3] 2,820
Cash dividends declared:              
Preferred stock (1,550)       (1,550)    
Common stock (44,864)       (44,864)    
Common stock repurchased (in shares) [4]   (3,594,000)          
Common stock repurchased [4] (53,436) $ (2,246)   (51,190)      
Common stock issued for:              
Stock options and restricted stock - equity awards (in shares)   382,000          
Stock options and restricted stock - equity awards 520 $ 239   281      
Stock-based compensation expense 5,432     5,432      
Dividends declared - noncontrolling interest of subsidiary preferred stock (2,820)           (2,820)
Balance, end of period (in shares) at Mar. 31, 2019   315,361,000          
Balance, end of period at Mar. 31, 2019 4,846,521 $ 197,101 95,624 2,983,948 1,595,568 (321,151) [3] 295,431
Balance, beginning of period (in shares) at Dec. 31, 2018   318,573,000          
Balance, beginning of period at Dec. 31, 2018 4,785,380 $ 199,108 95,624 3,029,425 1,542,408 (376,616) [3] 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 331,090            
Other comprehensive income/(loss) 135,962            
Comprehensive income/(loss) 467,052            
Cash dividends declared:              
Preferred stock (4,650)            
Balance, end of period (in shares) at Sep. 30, 2019   311,180,000          
Balance, end of period at Sep. 30, 2019 4,996,043 $ 194,487 95,624 2,925,309 1,725,846 (240,654) [3] 295,431
Balance, beginning of period (in shares) at Mar. 31, 2019   315,361,000          
Balance, beginning of period at Mar. 31, 2019 4,846,521 $ 197,101 95,624 2,983,948 1,595,568 (321,151) [3] 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 113,742       110,890   2,852
Other comprehensive income/(loss) 58,662         58,662 [3]  
Comprehensive income/(loss) 172,404       110,890 58,662 [3] 2,852
Cash dividends declared:              
Preferred stock (1,550)       (1,550)    
Common stock (44,388)       (44,388)    
Common stock repurchased (in shares) [4]   (3,654,000)          
Common stock repurchased [4] (52,222) $ (2,284)   (49,938)      
Common stock issued for:              
Stock options and restricted stock - equity awards (in shares)   771,000          
Stock options and restricted stock - equity awards 2,944 $ 482   2,462      
Stock-based compensation expense 5,224     5,224      
Dividends declared - noncontrolling interest of subsidiary preferred stock (2,852)           (2,852)
Balance, end of period (in shares) at Jun. 30, 2019   312,478,000          
Balance, end of period at Jun. 30, 2019 4,926,081 $ 195,299 95,624 2,941,696 1,660,520 (262,489) [3] 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 113,943       111,060   2,883
Other comprehensive income/(loss) 21,835         21,835 [3]  
Comprehensive income/(loss) 135,778       111,060 21,835 [3] 2,883
Cash dividends declared:              
Preferred stock (1,550)       (1,550)    
Common stock (44,184)       (44,184)    
Common stock repurchased (in shares) [4]   (1,804,000)          
Common stock repurchased [4] (28,382) $ (1,127)   (27,255)      
Common stock issued for:              
Stock options and restricted stock - equity awards (in shares)   506,000          
Stock options and restricted stock - equity awards 5,361 $ 315   5,046      
Stock-based compensation expense 5,822     5,822      
Dividends declared - noncontrolling interest of subsidiary preferred stock (2,883)           (2,883)
Balance, end of period (in shares) at Sep. 30, 2019   311,180,000          
Balance, end of period at Sep. 30, 2019 $ 4,996,043 $ 194,487 $ 95,624 $ 2,925,309 $ 1,725,846 $ (240,654) [3] $ 295,431
[1]
Due to the nature of the preferred stock issued by FHN and its subsidiaries, all components of Other comprehensive income/(loss) have been attributed solely to FHN as the controlling interest holder.
[2]
Third quarter 2018 includes $19.0 million of share repurchased under share repurchase programs.
[3]
Due to the nature of the preferred stock issued by FHN and its subsidiaries, all components of Other comprehensive income/(loss) have been attributed solely to FHN as the controlling interest holder.
[4] Third, second and first quarter 2019 include $28.2 million, $50.2 million and $51.5 million, respectively, of shares repurchased under share repurchase programs